Purpose

This study will determine the dose-response relationship of VAY736 for key efficacy and safety parameters

Category

IRB Number
20180118HU
NCT Number
-
Open to Enrollment
Yes
Sponsor
Novartis Pharmaceuticals -



Study Contact

Principal Investigator
Peter Fox

Mary Woolsey
(210) 567-8049
woolseym@uthscsa.edu



Eligibility

Eligible Ages
Between 18 Years and 75 Years
Eligible Genders
All
Accepts Healthy Volunteers
No

Inclusion Criteria

    Exclusion Criteria


      Study Design

      Arm Groups